Roy Kessous

Jewish General Hospital, McGill University

Papers

9

Total Citations

156

H-Index

6

About

Dr. Roy Kessous is a leading gynecologic oncologist whose research focuses on the transformative role of robotic surgery in the management of gynecologic cancers, particularly ovarian, cervical, and endometrial malignancies. His work critically evaluates both the clinical and financial implications of minimally invasive techniques. Dr. Kessous has made major contributions by demonstrating the safety and efficacy of robotic surgery after neoadjuvant chemotherapy for ovarian cancer (43 citations) and by comparing oncologic outcomes of robotic versus open radical hysterectomy for cervical cancer (31 citations). He has also pioneered research into patient-centered outcomes, including postoperative pain management and satisfaction, and has analyzed the economic impact of robotic programs, from reducing pain medication costs to optimizing resource utilization on inpatient wards. With over 150 total citations, his studies provide a comprehensive, three-pronged evaluation of robotic surgery—covering clinical outcomes, patient-reported experiences, and cost-effectiveness. Dr. Kessous’s work is instrumental in guiding the shift toward robotically-assisted surgical interfaces, offering a balanced view of their benefits and challenges in modern oncology care.

Research Focus

Key Achievements

6
H-Index
9
Papers
156
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy
43 citations · 2019
📈 Most Prolific Year: 2019 (3 Papers)
🤝 Key Collaborators: 36
🏛 Institutions: Jewish General Hospital, McGill University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago